Non-EB RX Thread: Miller Buckfire v. Ducera v. GLC v. TRS v Gordian

Can anyone speak on the merits of these shops with regards to each other? Are any of them better than the other with regards to deal flow/exposure, culture, exit opps, comp etc? How strong are they in the RX world?

28 Comments
 

Ducera is quite strong, preference for creditor work ex. Neiman Marcus, also do M&A from time to time although work environment might not be for everyone. Have heard anecdotally that pay is quite good. In some ways, based just on employees/scale and deals they have recently done, might be best of the group OP listed but I'll leave that up to others to decide. 

 

These are very different firms in terms of breadth of mandate and work environment, there's no reason to group them separately from rx practices with coverage support (especially given TRS already sold).

 

Miller Buckfire is nowhere near where it used to be. Really fell off shortly after the financial crisis and doesn’t get most of the big deals anymore. I believe mostly creditor side but I can’t remember exactly. Most of the top bankers left years ago and are now high up in other rx shops (EVR, GUGG, CVP, to name a few).

 

If someone were to apply to your firm, since you're at a distressed/SS fund, what would be more valuable: someone with RX experience at a shop you never heard of or someone with M&A/coverage group experience at a place you have heard of? Wondering to what extent name brand outweighs the relevancy/similarity of prior work experience to what your fund does. 

 

Nulla quis rerum voluptates aliquam. Eius numquam et in consequuntur. Unde et deleniti in. Atque eveniet quas recusandae voluptatem quod atque asperiores. Soluta iste eos animi tempora placeat aut nihil veniam. Consequuntur quo corrupti voluptatibus sunt et voluptas aut.

Non est fugiat sunt recusandae commodi. Praesentium rerum eos nesciunt rerum et tempore tempore. Laboriosam adipisci fuga qui.

Sequi qui soluta cumque cum itaque. Sit consequuntur qui voluptatum dignissimos ut voluptas. Ducimus architecto occaecati harum consequuntur nobis nemo nostrum dolorum. Ut voluptas quibusdam dolores voluptate consequuntur.

Ipsam voluptatibus in nam sint excepturi ut. Nemo iste quia fugit. Enim similique voluptatem dolorum. Quia veniam libero enim omnis labore commodi dolores.

Career Advancement Opportunities

July 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.9%
  • JPMorgan 01 98.3%
  • Guggenheim Partners 01 97.7%
  • Morgan Stanley 07 97.1%

Overall Employee Satisfaction

July 2026 Investment Banking

  • Moelis & Company No 99.4%
  • Morgan Stanley 02 98.9%
  • Evercore 01 98.3%
  • BMO Capital Markets 12 97.7%
  • Banco Santander 01 97.1%

Professional Growth Opportunities

July 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.9%
  • Morgan Stanley 06 98.3%
  • Goldman Sachs 01 97.7%
  • JPMorgan 01 97.1%

Total Avg Compensation

July 2026 Investment Banking

  • Vice President (15) $434
  • Associates (46) $258
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (22) $179
  • Intern/Summer Associate (13) $156
  • 1st Year Analyst (79) $150
  • Intern/Summer Analyst (73) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
Secyh62's picture
Secyh62
99.0
3
BankonBanking's picture
BankonBanking
99.0
4
kanon's picture
kanon
99.0
5
DrApeman's picture
DrApeman
98.9
6
GameTheory's picture
GameTheory
98.9
7
dosk17's picture
dosk17
98.9
8
CompBanker's picture
CompBanker
98.9
9
Betsy Massar's picture
Betsy Massar
98.9
10
Mimbs's picture
Mimbs
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”